Alexion
Alexion makes $8.4 billion Synageva purchase
May 7, 2015Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva
Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …
NICE approves world’s most expensive drug
January 28, 2015Sales and Marketing Alexion, Dillon, NHS, NICE, aHUS, eculizumab, hst, soliris
The world’s most expensive drug has been approved in final guidance from NICE, making it the first drug to pass …
NHS to get world’s most expensive drug
November 27, 2014Sales and Marketing Alexion, NICE, aHUS, beauchamp, blood, eculizumab, soliris
UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS). Soliris …
NICE backs world’s most expensive medicine
September 4, 2014Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris
In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …
Pharma manufacturing news in brief
February 17, 2014Manufacturing and Production Advaxis, Alexion, Berkshire Sterile Manufacturing, Catalent, Hospira, Shire
Hospira has made significant progress in restoring quality compliance at its facilities in Rocky Mount and Austin, which were the …
Strong growth for Roche in latest results
July 25, 2013Sales and Marketing Alexion, Q2, Rituxan, Roche
Roche has seen strong sales growth in the past six months as it lines up new products to replace its …
Roche ‘considers’ Alexion bid
July 16, 2013Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris
Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …
Pharma manufacturing news in brief
September 7, 2010Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys
A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …
Manufacturing news in brief
December 14, 2009Manufacturing and Production Alexion, Codexis, Dishman, Dow
Pharmafocus’ round-up of developments in pharmaceutical manufacturing includes facility updates from Dishman, Alexion, Stirling Products, RL Fine Chemicals and Cambrex, …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
